Western Blot data demonstrating successful knockdown of TLR7 in human cells 48 hours after treatment with QX26 siRNA (TC = Transfection Control, siRNA = QX26 treatment)
Western Blot data demonstrating successful knockdown of TLR7 in human cells 48 hours after treatment with QX26 siRNA (TC = Transfection Control, siRNA = QX26 treatment)

TranslationBlocker Human TLR7 / CD287 siRNA

$ 219.00$ 329.00
Please Select Product Options Below To View The Catalog Number.

Human TLR7 / CD287 siRNA Translation Blocker™ Duplex

Product NumberDescriptionPrice
QX26-2nmol : 2-nmol: untagged $ 219.00
QX26-10nmol : 10-nmol: untagged $ 329.00
Shipping Information
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
SKU: QX26-2nmol

Human TLR7 / CD287 TranslationBlocker™ siRNA Duplex Product Attributes

Blocks transcription and translation of TLR7 / CD287 from: Human.
May also react with TLR7 / CD287 based upon sequence homology and clone specific publications.
Type of RNAi: siRNA.
siRNA target sequence: NM_016562.
Samples and cell lines tested: 293T Human Embryonic Kidney Cells with Large T Antigen.
Buffer and Stabilizer: Lyophilized. See datasheet for resuspension instructions and buffer information.
Concentration of Anti-Human TLR7 / CD287: Lyophilized
SiRNA Purification Method:RPC/HPLC
Storage Conditions: Store Lyophilized siRNA duplex at 4C. Reconsituted product may be stored at -20C for up to 1 month.
    TLR7 / CD287 Knockdown Protocol:
    1. Starting with cultured cells in growth media seed plates with cells and incubated at 37°C. The above data was generated in 6 well plates with 1.2x106 cells.
    2. Prepare transfection reagent in serum-free growth medium such as Opti-MEM-I. Allow to come to room temperature. Lipofectamine 2000 was used to generate the above data in accordance with manufacturer’s instructions. li>
    3. Dilute siRNA to working concentration in serum-free growth media. For Lipofectamine or similar transfections into 6 well plates, we recommend starting siRNA dose optimization at around 150 pmol siRNA duplex.Optimal dilution should be experimentally determined.
    4. Combine diluted siRNA and transfection reagent. Equivalent volumes of prepared Lipofectamine 2000 or other transfection reagent and diluted siRNA should be combined and incubated at room temperature for 30 minutes with gentle mixing (optional).
    5. Add prepared siRNA solution to cells. For 6 well plates this will entail adding the solution to cells in approximately 2.5 ml serum-free medium. Optionally, FITC labeled control siRNA (Product Number QC-1F) or positive control siRNA (Beta-Actin; Product Number QC-2) may be used to assess transfection efficiency.
    6. Incubate for several hours in serum free media. The above data was generated with a 4 hour incubation.
    7. Add serum containing media to culture without a media change if longer incubation times are required. Generally 1-2 fold of the original volume of siRNA containing serum-free media is added to restore nutrient levels in media. Alternatively, the media may be directly supplemented with serum such as 10% FBS.
    8. Incubate and assay several hours after transfection. Optimal knockdown time should also be experimentally determined. Optionally, a second transfection can be performed 24 hours after the first transfection to enhance knockdown. TLR7 knockdown at the protein level was measured at 48 hours post transfection via Western Blot.

TLR7 / CD287 General Information

Gene Name: TLR7
Entrez Gene ID: 51284
NCBI Ref Seq Accession Number: NP_057646
Uniprot ID:
TLR7 / CD287 Molecular Weight:
Alternate Names: TLR7-like, TLR7, Toll-like receptor 7, TLR-7

Limitations and Warranty

This product is for Research Use Only. This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.

There are no reviews yet.

Be the first to review “TranslationBlocker Human TLR7 / CD287 siRNA”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title

Materials

Methods

Notes


  protocol submission gif

enQuire Bio, LLC   1825 Lawrence St, Ste 115   Denver, CO 80202
Phone: 1-855-344-1400 | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

TranslationBlocker Human TLR7 / CD287 siRNA

https://enquirebio.com/wp-content/uploads/2017/07/QX26-2nmol-TLR7-CD287-RNAi-data.jpg